Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid

Metabolism: Clinical and Experimental

Volumn 56, Issue 6, 2007, Pages 751-756

  Lin, Jen Der ^a   Chiou, Wen Ko ^b   Chang, Hung Yu ^a   Liu, Feng Hsuan ^a   Weng, Hsiao Fen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; TRIACYLGLYCEROL; URIC ACID;

ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; WAIST HIP RATIO;

ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; URIC ACID; WAIST-HIP RATIO;

EID: 34248403683     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.01.006     Document Type: Article

References (30)

1. Chien K.L., Hsu H.C., Sung F.C., et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan community cardiovascular cohort study. Atherosclerosis 183 (2005) 147-155
2. Pladevall M., Singal B., Williams L.K., et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 29 (2006) 113-122
3. Yoo T.W., Sung K.C., Shin H.S., et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69 (2005) 928-933
4. Bonora E., Targher G., Zenere M.B., et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20 (1996) 975-980
5. Tang W., Hong Y., Province M.A., et al. Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. Diabetes Care 29 (2006) 631-636
6. Guidelines Subcommittee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 17 (1999) 151-183
7. Chang H.Y., Pan W.H., Yeh W.T., et al. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 28 (2001) 1640-1646
8. Allain C.C., Poon L.S., Chan C.S., et al. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
9. Bucolo G., and David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19 (1973) 476-482
10. Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 20 (1997) 1087-1092
11. Lin J.D., Chiou W.K., Chang H.Y., et al. Association of hematological factors with components of the metabolic syndrome in older and younger adults. Aging Clin Exp Res 18 (2006) 477-484
12. SAS Institute, Inc. SAS/STAT user's guide, version 6. 4th ed. (1990), SAS Institute, Inc, Cary (NC)
13. Bonora E., Eiechl S., Willeit J., et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47 (1998) 1643-1649
14. Matsuura F., Yamashita S., Nakamura T., et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47 (1998) 929-933
15. Culleton B.F., Larson M.G., Kannel W.B., et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131 (1999) 7-13
16. Kanellis J., Feig D.I., and Johnson R.J. Does asymptomatic hyperuricemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Calton) 9 (2004) 394-399
17. Lee M.S., Lin S.C., Chang H.Y., et al. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr 14 (2005) 285-292
18. Alper Jr. A.B., Chen W., Yau L., et al. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45 (2005) 34-38
19. Lin J.D., Chiou W.K., Weng H.F., et al. Application of three dimensional body scanner: observation of prevalence of metabolic syndrome. Clin Nutr 23 (2004) 1313-1323
20. Chiou W.K., Lin J.D., Weng H.F., et al. Correlation of the dysmetabolic risk factors with different anthropometric measurements. Endocr J 52 (2005) 139-148
21. Hsieh S.D., Yoshinaga H., and Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 27 (2003) 610-616
22. Vuorinen-Markkola H., and Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78 (1994) 25-29
23. Lai S.W., Tan C.K., and Ng K.C. Epidemiology of hyperuricemia in the elderly. Yale J Biol Med 74 (2001) 151-157
24. Tomota M., Mizuno S., Yamanaka H., et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 10 (2000) 403-409
25. Johnson R.J., Kivlighn S.D., Kim Y.G., et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33 (1999) 225-234
26. Matsubara M., Chiba H., Maruoka S., et al. Elevated serum leptin concentrations in women with hyperuricemia. J Atheroscler Thromb 9 (2002) 28-34
27. Bedir A., Topbas M., Tanyeri F., et al. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44 (2003) 527-536
28. Correia M.L., and Rahmouni K. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes Metab 8 (2006) 603-610
29. Shishehbor M.H., Hoogwerf B.J., and Lauer M.S. Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery. Diabetes Care 27 (2004) 936-941
30. Bhalodkar N.C., Blum S., and Enas E.A. Accuracy of the ratio of triglyceride to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle size, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol 97 (2006) 1007-1009